Mandate

Vinge advises Borgo in connection with its acquisition of a mortgage loan portfolio, assumption of covered bonds and establishment of its commercial paper programme

February 15, 2022 Banking and Finance M&A

Vinge has advised Borgo AB (publ) (“Borgo”) in connection with its acquisition of the majority of Ålandsbanken’s Swedish mortgage loan portfolio of SEK 10,5 billion and its parallel assumption of Ålandsbanken’s issued covered bonds of SEK 7,5 billion. Vinge has also advised Borgo with the establishment of its SEK 10 billion commercial paper programme, under which Borgo may issue commercial papers denominated in either SEK or EUR.

The acquisition of the mortgage loan portfolio is a continuation of the collaboration that began in the autumn of 2019 between ICA Banken, Ikano Bank, Söderberg & Partners, Ålandsbanken and Borgo. As part of the collaboration, Borgo will act as lender, and ICA Banken, Ikano Bank, Söderberg & Partners, Ålandsbanken and Sparbanken Syd will act as credit intermediaries, mediating mortgage loans under their own brands and with their own offers.

Vinge’s team mainly consisted of Johan Larsson, Joacim Rydegård and Carl Fredrik Wachtmeister (M&A), Mikael Ståhl, Lionardo Ojeda, Axel Jansson and Felix Möller (Banking and Finance) and Caroline Krassén (Financial Services).

 

Related

Vinge advises Sobro on its investment in Västkustens Konstruktionsbyrå

Västkustens Konstruktionsbyrå has decided to broaden its ownership structure by bringing in Sobro as a new co-partner and majority shareholder. The founders will remain with the company as the CEO and CTO respectively, and as significant shareholders. Västkustens Konstruktionsbyrå is an engineering consultancy company based in Gothenburg with cutting-edge expertise in project management, civil engineering and design.
April 23, 2026

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of SEK 350 million before transaction costs.
April 22, 2026

Vinge has advised Alder on the establishment of Alder Strategic Opportunities Fund I and on a fund credit facility agreement in connection with the fundraising

Vinge has advised Alder on the establishment of the continuation fund Alder Strategic Opportunities Fund I AB. In connection with the establishment, the fund acquires the portfolio companies SI and SMG from Alder II. Vinge also advised Alder on the entering into of a fund credit facility agreement with SEB.
April 20, 2026